class action lawsuit

BellRing Brands faces securities fraud lawsuit for allegedly failing to disclose significant inventory issues. Stock fell 52% during the class period amid operational challenges.

Class action lawsuit filed against PayPal for allegedly making false statements about 2027 financial targets and Branded Checkout expansion while concealing sales organization problems.

Law firm investigates Beta Bionics for potential securities fraud after stock plunged 37% due to slowing patient growth, missing investor expectations on guidance accuracy.

Law firm investigates Ashford Hospitality Trust for potential securities violations following dividend suspension and mortgage disclosure. Stock fell 8.1%.

Law firm Pomerantz LLP investigates First Western Financial for potential securities violations following earnings miss and 8.81% stock drop on January 23, 2026.

Pomerantz investigates First Citizens BancShares for potential securities fraud following disappointing Q4 earnings and weak guidance, triggering an 8.49% stock decline.

Law firm investigates Celestica for potential securities fraud after reports Google may shift TPU assembly work to other suppliers, raising disclosure concerns.

Pomerantz launches class action against Vistagen after failed clinical trial caused 80% stock drop. March 16, 2026 deadline for investors to join lawsuit.

Class action lawsuit filed against China Liberal Education for alleged securities fraud involving fraudulent social media advisors that artificially inflated stock prices before collapse.

Oracle faces securities lawsuit for allegedly misrepresenting AI infrastructure investment returns and failing to disclose significant financial obligations and project delays.

Ralliant Corporation faces securities investigation over $1.4B impairment charge. Stock plunged 31.8%, raising questions about delayed disclosure of material information to investors.

Law firm Block & Leviton investigates GEMI for potential securities violations after three senior executives departed amid 10% stock decline and 25% workforce reduction.

Portnoy Law Firm files class action against Oracle for failing to timely disclose a $15 billion CapEx increase tied to its OpenAI partnership deal.

Law firm sues Quantum Biopharma for alleged market manipulation through spoofed sell orders, claiming defendants artificially suppressed stock price from 2021-2025.

Pomerantz Law Firm files class action against Quantum Biopharma, alleging Canadian banks used spoofed orders to artificially depress stock price and buy shares at reduced rates.

Schall Law Firm launches class action against Inovio Pharmaceuticals for alleged misrepresentations about manufacturing capabilities and regulatory timelines. Investors can join until April 7, 2026.

Mereo BioPharma faces class action lawsuit over allegedly misleading disclosures about failed Phase 3 clinical trials. Investors who purchased shares between June 2023 and December 2025 may be eligible.

Class action lawsuit filed against agilon health for allegedly making false 2026 guidance claims and overstating benefits of risk reduction initiatives, affecting investors from February-August 2025.

REGENXBIO faces class action lawsuit alleging false statements about RGX-111 gene therapy trial results, covering securities purchased between February 2022 and January 2026.

Klarna faces class action lawsuit alleging it misrepresented loan portfolio risks and understated credit exposure in its September 2025 IPO.